Cause	cause	O	O	O	O
of	of	O	O	O	O
death	death	O	DISEASE	OTHERS	I
among	among	O	O	O	O
patients	patients	O	O	O	O
with	with	O	O	O	O
Parkinson	parkinson	O	DISEASE	OTHERS	I
's	's	O	DISEASE	OTHERS	I
disease	disease	O	DISEASE	OTHERS	I
:	:	O	O	O	O
a	a	O	O	O	O
rare	rare	O	O	O	O
mortality	mortality	O	O	O	O
due	due	O	O	O	O
to	to	O	O	O	O
cerebral	cerebral	O	DISEASE	OTHERS	I
haemorrhage	haemorrhage	O	DISEASE	OTHERS	I
.	.	O	O	O	O

Causes	causes	O	O	O	O
of	of	O	O	O	O
death	death	O	DISEASE	OTHERS	I
,	,	O	O	O	O
with	with	O	O	O	O
special	special	O	O	O	O
reference	reference	O	O	O	O
to	to	O	O	O	O
cerebral	cerebral	O	DISEASE	OTHERS	I
haemorrhage	haemorrhage	O	DISEASE	OTHERS	I
,	,	O	O	O	O
among	among	O	O	O	O
240	240	O	O	O	O
patients	patients	O	O	O	O
with	with	O	O	O	O
pathologically	pathologically	O	O	O	O
verified	verified	O	O	O	O
Parkinson	parkinson	O	DISEASE	OTHERS	I
's	's	O	DISEASE	OTHERS	I
disease	disease	O	DISEASE	OTHERS	I
were	were	O	O	O	O
investigated	investigated	O	O	O	O
using	using	O	O	O	O
the	the	O	O	O	O
Annuals	annuals	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
Pathological	pathological	O	O	O	O
Autopsy	autopsy	O	O	O	O
Cases	cases	O	O	O	O
in	in	O	O	O	O
Japan	japan	O	O	O	O
from	from	O	O	O	O
1981	1981	O	O	O	O
to	to	O	O	O	O
1985	1985	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
leading	leading	O	O	O	O
causes	causes	O	O	O	O
of	of	O	O	O	O
death	death	O	DISEASE	OTHERS	I
were	were	O	O	O	O
pneumonia	pneumonia	O	O	OTHERS	I
and	and	O	O	O	O
bronchitis	bronchitis	O	O	OTHERS	I
(	(	O	O	O	O
44.1	44.1	O	O	O	O
%	%	O	O	O	O
)	)	O	O	O	O
,	,	O	O	O	O
malignant	malignant	O	O	O	O
neoplasms	neoplasms	O	O	OTHERS	I
(	(	O	O	O	O
11.6	11.6	O	O	O	O
%	%	O	O	O	O
)	)	O	O	O	O
,	,	O	O	O	O
heart	heart	O	DISEASE	OTHERS	I
diseases	diseases	O	DISEASE	OTHERS	I
(	(	O	O	O	O
4.1	4.1	O	O	O	O
%	%	O	O	O	O
)	)	O	O	O	O
,	,	O	O	O	O
cerebral	cerebral	O	DISEASE	OTHERS	I
infarction	infarction	O	DISEASE	OTHERS	I
(	(	O	O	O	O
3.7	3.7	O	O	O	O
%	%	O	O	O	O
)	)	O	O	O	O
and	and	O	O	O	O
septicaemia	septicaemia	O	O	OTHERS	I
(	(	O	O	O	O
3.3	3.3	O	O	O	O
%	%	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

Cerebral	cerebral	O	DISEASE	OTHERS	I
haemorrhage	haemorrhage	O	DISEASE	OTHERS	I
was	was	O	O	O	O
the	the	O	O	O	O
11th	11th	O	O	O	O
most	most	O	O	O	O
frequent	frequent	O	O	O	O
cause	cause	O	O	O	O
of	of	O	O	O	O
death	death	O	DISEASE	OTHERS	I
,	,	O	O	O	O
accounting	accounting	O	O	O	O
for	for	O	O	O	O
only	only	O	O	O	O
0.8	0.8	O	O	O	O
%	%	O	O	O	O
of	of	O	O	O	O
deaths	deaths	O	DISEASE	OTHERS	I
among	among	O	O	O	O
the	the	O	O	O	O
patients	patients	O	O	O	O
,	,	O	O	O	O
whereas	whereas	O	O	O	O
it	it	O	O	O	O
was	was	O	O	O	O
the	the	O	O	O	O
5th	5th	O	O	O	O
most	most	O	O	O	O
common	common	O	O	O	O
cause	cause	O	O	O	O
of	of	O	O	O	O
death	death	O	DISEASE	OTHERS	I
among	among	O	O	O	O
the	the	O	O	O	O
Japanese	japanese	O	O	O	O
general	general	O	O	O	O
population	population	O	O	O	O
in	in	O	O	O	O
1985	1985	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
low	low	O	O	O	O
incidence	incidence	O	O	O	O
of	of	O	O	O	O
cerebral	cerebral	O	DISEASE	OTHERS	I
haemorrhage	haemorrhage	O	DISEASE	OTHERS	I
as	as	O	O	O	O
a	a	O	O	O	O
cause	cause	O	O	O	O
of	of	O	O	O	O
death	death	O	DISEASE	OTHERS	I
in	in	O	O	O	O
patients	patients	O	O	O	O
with	with	O	O	O	O
Parkinson	parkinson	O	DISEASE	OTHERS	I
's	's	O	DISEASE	OTHERS	I
disease	disease	O	DISEASE	OTHERS	I
may	may	O	O	O	O
reflect	reflect	O	O	O	O
the	the	O	O	O	O
hypotensive	hypotensive	O	DISEASE	OTHERS	I
effect	effect	O	O	O	O
of	of	O	O	O	O
levodopa	levodopa	CHEMICALS	O	OTHERS	I
and	and	O	O	O	O
a	a	O	O	O	O
hypotensive	hypotensive	O	DISEASE	OTHERS	I
mechanism	mechanism	O	O	O	O
due	due	O	O	O	O
to	to	O	O	O	O
reduced	reduced	O	O	O	O
noradrenaline	noradrenaline	CHEMICALS	O	OTHERS	I
levels	levels	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
parkinsonian	parkinsonian	O	DISEASE	OTHERS	I
brain	brain	O	O	O	O
.	.	O	O	O	O

